Prospera Financial Services Inc Boosts Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Prospera Financial Services Inc raised its position in iShares Biotechnology ETF (NASDAQ:IBB) by 5.6% during the third quarter, Holdings Channel.com reports. The firm owned 2,880 shares of the financial services provider’s stock after buying an additional 152 shares during the period. Prospera Financial Services Inc’s holdings in iShares Biotechnology ETF were worth $419,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Main Management ETF Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 2.6% during the second quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock worth $79,451,000 after purchasing an additional 14,535 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its stake in shares of iShares Biotechnology ETF by 24.6% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock valued at $29,792,000 after acquiring an additional 42,822 shares during the last quarter. Raymond James & Associates increased its stake in shares of iShares Biotechnology ETF by 4.4% during the 2nd quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after acquiring an additional 7,931 shares during the last quarter. Albion Financial Group UT lifted its holdings in shares of iShares Biotechnology ETF by 0.3% during the 3rd quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock worth $18,925,000 after acquiring an additional 356 shares during the period. Finally, State of Michigan Retirement System boosted its position in shares of iShares Biotechnology ETF by 150.0% in the second quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after acquiring an additional 75,000 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $137.96 on Monday. iShares Biotechnology ETF has a 1 year low of $117.28 and a 1 year high of $150.57. The firm has a 50 day moving average price of $143.43 and a 200 day moving average price of $141.87.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.